Global Transdermal patches Market Size, Trends, and Growth Opportunity, By Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, Others), By Application (Cardiovascular, CNS, Pain Management, Dermatology, Others), By Technology (Electric current, Mechanical arrays, Thermal Ablation, Chemical Enhancers, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East) and Forecast till 2030.
Global Transdermal Patches Market
The Global Transdermal patches Market was valued at USD 7.10 billion in 2022 and is expected to expand to USD 11.95 billion in 2030 at a CAGR of 6.72 % during the forecast period 2023-2030.
Transdermal patches are the medicated type of adhesive patches. They help in delivering a desired dose of medication inside the body by using the transdermal system and diffusion technique. The medication enters into the bloodstream over a while. These patches are used for various diseases and their benefits include painless administration of medicine and prolonged activity of the drug making them useful among old aged people and youth.
Market Drivers
The rising technological advancements in transdermal drug delivery systems along with various advantages like painless administration of medication drive the Transdermal patches market growth during the forecast period.
Furthermore, the transdermal patches are useful in the joint, muscular, paining points, and other chronic diseases propelling the growth of the market. Additionally, the growing number of people quitting smoking increases the demand for nicotine patches which boosts the market growth.
Market Restraints
The increasing inability of the skin to absorb a large range of medications and rising chances of the development of contact dermatitis or other skin infections at the site of application hinder the growth of the transdermal patches market.
COVID-19 Impact on Transdermal patches Market
The outbreak of covid-19 negatively impacted the market as restrictions and lockdowns were imposed by the government to protect public health, and production was disrupted. Also, the travel restrictions and moving the focus of people to protection from covid -19 pandemic decline the use of transdermal patches.
Impact of Russia Ukraine War on the Market
The conflict between Russia and Ukraine can have both direct and indirect impacts on the transdermal patches market:
Disruptions in the supply chain: Many transdermal patch manufacturers source components from Russia and Ukraine. The war may cause supply chain disruptions and delays, affecting transdermal patches production and delivery.
Economic sanctions: Economic sanctions imposed on Russia may have an impact on the overall economy, as well as the demand for transdermal patches in the region.
Market Segmentation
The Global Transdermal patches Market is segmented on the basis of Type, Application, Technology, and Region. Based on Type, it is segmented into Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, and Others. Based on Application, it is segmented into Cardiovascular, CNS, Pain Management, Dermatology, and Others. Based on Technology, it is segmented into Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others. Based on Region, it is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Regional Analysis
North America is likely to dominate the market over the forecast period owing to the rising advancement in healthcare infrastructure, growing government initiatives along with support, rising adoption of product innovation by people, and a growing population with chronic disease in this region.
Key Players
Various key players are listed in this report such as AdhexPharma, ProSolus Inc, Tapemark, Tesa Labtec GmbH, Nitto Denko Corporation, Noven Pharmaceuticals Inc, Therapie-Systeme AG, Medherant Limited, Corium International Inc, ANI Pharmaceuticals Inc, Novartis AG, Janssen Pharmaceuticals Inc, Antares Pharma, Aneva Drug Delivery Systems, Medipatch Inc.
Market Taxonomy
By Type
• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Others
By Application
• Cardiovascular
• CNS
• Pain Management
• Dermatology
• Others
By Technology
• Electric Current
• Mechanical Arrays
• Thermal Ablation
• Chemical Enhancers
• Others
By Region
• North America
• U.S.
• Canada
• Mexico
• Latin America
• Brazil
• Malaysia
• Colombia
• Peru
• Chile
• Venezuela
• Rest of Latin America
• Europe
• Germany
• France
• UK
• Russia
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• New Zealand
• Singapore
• Malaysia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Venezuela
Key Question Addressed by the Report
• What are the Key Opportunities in the Global Transdermal patches Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the role of key players in the value chain?
Global Transdermal Patches Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Transdermal Patches Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Transdermal Patches Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Transdermal Patches Market Share Analysis, By Type
5.3 Transdermal Patches Market Size and Forecast, By Type
5.3.1 Single-layer Drug-in-Adhesive
5.3.2 Multi-layer Drug-in-Adhesive
5.3.3 Matrix
5.3.4 Others
6 Transdermal Patches Market, By Technology
6.1 Y-o-Y Growth Comparison, By Technology
6.2 Transdermal Patches Market Share Analysis, By Technology
6.3 Transdermal Patches Market Size and Forecast, By Technology
6.3.1 Electric current
6.3.2 Mechanical arrays
6.3.3 Thermal Ablation
6.3.4 Chemical Enhancers
6.3.5 Others
7 Transdermal Patches Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Transdermal Patches Market Share Analysis, By Application
7.3 Transdermal Patches Market Size and Forecast, By Application
7.3.1 Cardiovascular
7.3.2 CNS
7.3.3 Pain Management
7.3.4 Dermatology
7.3.5 Others
8 Transdermal Patches Market, By Region
8.1 Transdermal Patches Market Share Analysis, By Region
8.2 Transdermal Patches Market Share Analysis, By Region
8.3 Transdermal Patches Market Size and Forecast, By Region
9 North America Transdermal Patches Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Transdermal Patches Market Share Analysis, By Type
9.3 North America Transdermal Patches Market Share Analysis, By Technology
9.4 North America Transdermal Patches Market Share Analysis, By Application
9.5 North America Transdermal Patches Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Type
9.5.1.2 Market Size and Forecast, By Technology
9.5.1.3 Market Size and Forecast, By Application
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Type
9.5.2.2 Market Size and Forecast, By Technology
9.5.2.3 Market Size and Forecast, By Application
9.5.3 Mexico
9.5.3.1Market Size and Forecast, By Type
9.5.3.2 Market Size and Forecast, By Technology
9.5.3.3 Market Size and Forecast, By Application
10 Europe Transdermal Patches Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Transdermal Patches Market Share Analysis, By Type
10.3 Europe Transdermal Patches Market Size and Forecast, By Technology
10.4 Europe Transdermal Patches Market Size and Forecast, By Application
10.5 Europe Transdermal Patches Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Type
10.5.1.2 Market Size and Forecast, By Technology
10.5.1.3 Market Size and Forecast, By Application
10.5.2 France
10.5.2.1 Market Size and Forecast, By Type
10.5.2.2 Market Size and Forecast, By Technology
10.5.2.3 Market Size and Forecast, By Application
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Type
10.5.3.2 Market Size and Forecast, By Technology
10.5.3.3 Market Size and Forecast, By Application
10.5.4 Russia
10.5.4.1 Market Size and Forecast, By Type
10.5.4.2 Market Size and Forecast, By Technology
10.5.4.3 Market Size and Forecast, By Application
10.5.5 Italy
10.5.5.1 Market Size and Forecast, By Type
10.5.5.2 Market Size and Forecast, By Technology
10.5.5.3 Market Size and Forecast, By Application
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Type
10.5.6.2 Market Size and Forecast, By Technology
10.5.6.3 Market Size and Forecast, By Application
10.5.7. Rest of Europe
10.5.7.1 Market Size and Forecast, By Type
10.5.7.2 Market Size and Forecast, By Technology
10.5.7.3 Market Size and Forecast, By Application
11 Asia Pacific Transdermal Patches Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Transdermal Patches Market Share Analysis, By Type
11.3 Asia Pacific Transdermal Patches Market Share Analysis, By Technology
11.4 Asia Pacific Transdermal Patches Market Share Analysis, By Application
11.5 Asia Pacific Transdermal Patches Market Share Analysis, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Type
11.5.1.2 Market Size and Forecast, By Technology
11.5.1.3 Market Size and Forecast, By Application
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Type
11.5.2.2 Market Size and Forecast, By Technology
11.5.2.3 Market Size and Forecast, By Application
11.5.3 India
11.5.3.1 Market Size and Forecast, By Type
11.5.3.2 Market Size and Forecast, By Technology
11.5.3.3 Market Size and Forecast, By Application
11.5.4 South Korea
11.5.4.1Market Size and Forecast, By Type
11.5.4.2 Market Size and Forecast, By Technology
11.5.4.3 Market Size and Forecast, By Application
11.5.5 Australia
11.5.5.1 Market Size and Forecast, By Type
11.5.5.2 Market Size and Forecast, By Technology
11.5.5.3 Market Size and Forecast, By Application
11.5.6 Newzealand
11.5.6.1 Market Size and Forecast, By Type
11.5.6.2 Market Size and Forecast, By Technology
11.5.6.3 Market Size and Forecast, By Application
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Type
11.5.7.2 Market Size and Forecast, By Technology
11.5.7.3 Market Size and Forecast, By Application
11.5.8 Malaysia
11.5.8.1 Market Size and Forecast, By Type
11.5.8.2 Market Size and Forecast, By Technology
11.5.8.3 Market Size and Forecast, By Application
11.5.9. Rest of Asia Pacific
11.5.9.1 Market Size and Forecast, By Type
11.5.9.2 Market Size and Forecast, By Technology
11.5.9.3 Market Size and Forecast, By Application
12 Latin America Transdermal Patches Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Transdermal Patches Market Share Analysis, By Type
12.3 Latin America Transdermal Patches Market Share Analysis, By Technology
12.4 Latin America Transdermal Patches Market Share Analysis, By Application
12.4 Latin America Transdermal Patches Market Share Analysis Country
12.5.1. Brazil
12.5.1.1Market Size and Forecast, By Type
12.5.1.2 Market Size and Forecast, By Technology
12.5.1.3 Market Size and Forecast, By Application
12.5.2 Malaysia
12.5.2.1Market Size and Forecast, By Type
12.5.2.2 Market Size and Forecast, By Technology
12.5.2.3 Market Size and Forecast, By Application
12.5.3 Colombia
12.5.3.1 Market Size and Forecast, By Type
12.5.3.2 Market Size and Forecast, By Technology
12.5.3.3 Market Size and Forecast, By Application
12.5.4 Peru
12.5.4.1Market Size and Forecast, By Type
12.5.4.2 Market Size and Forecast, By Technology
12.5.4.3 Market Size and Forecast, By Application
12.5.5 Chile
12.5.5.1Market Size and Forecast, By Type
12.5.5.2 Market Size and Forecast, By Technology
12.5.5.3 Market Size and Forecast, By Application
12.5.6 Venezuela
12.5.6.1Market Size and Forecast, By Type
12.5.6.2 Market Size and Forecast, By Technology
12.5.6.3 Market Size and Forecast, By Application
12.5.7. Rest of Latin America
12.5.7.1Market Size and Forecast, By Type
12.5.7.2 Market Size and Forecast, By Technology
12.5.7.3 Market Size and Forecast, By Application
13 Middle East Transdermal Patches Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Transdermal Patches Market Share Analysis, By Type
13.3 Middle East Transdermal Patches Market Size and Forecast, By Technology
13.4 Middle East Transdermal Patches Market Size and Forecast, By Application
13.5 Middle East Transdermal Patches Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.1.1 Market Size and Forecast, By Type
13.5.1.2 Market Size and Forecast, By Technology
13.5.1.3 Market Size and Forecast, By Application
13.5.2. UAE
13.5.2.1 Market Size and Forecast, By Type
13.5.2.2 Market Size and Forecast, By Technology
13.5.2.3 Market Size and Forecast, By Application
13.5.3. Egypt
13.5.3.1 Market Size and Forecast, By Type
13.5.3.2 Market Size and Forecast, By Technology
13.5.3.3 Market Size and Forecast, By Application
13.5.4. Kuwait
13.5.4.1Market Size and Forecast, By Type
13.5.4.2 Market Size and Forecast, By Technology
13.5.4.3 Market Size and Forecast, By Application
13.5.5. South Africa
13.5.5.1Market Size and Forecast, By Type
13.5.5.2 Market Size and Forecast, By Technology
13.5.5.3 Market Size and Forecast, By Application
13.5.6 Venezuela
13.5.6.1Market Size and Forecast, By Type
13.5.6.2 Market Size and Forecast, By Technology
13.5.6.3 Market Size and Forecast, By Application
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 AdhexPharma
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 ProSolus Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Tapemark
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Tesa Labtec GmbH
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Nitto Denko Corporation
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Noven Pharmaceuticals Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Therapie-Systeme AG
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Medherant Limited
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Corium International Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 ANI Pharmaceuticals Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 Novartis AG
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
15.12 Janssen Pharmaceuticals Inc
15.12.1 Overview
15.12.2 Offerings
15.12.3 Key Financials
15.12.4 Business Segment & Geographic Overview
15.12.5 Key Market Developments
15.12.6 Key Strategies
15.13 Antares Pharma
15.13.1 Overview
15.13.2 Offerings
15.13.3 Key Financials
15.13.4 Business Segment & Geographic Overview
15.13.5 Key Market Developments
15.13.6 Key Strategies
15.14 Aneva Drug Delivery Systems
15.14.1 Overview
15.14.2 Offerings
15.14.3 Key Financials
15.14.4 Business Segment & Geographic Overview
15.14.5 Key Market Developments
15.14.6 Key Strategies
15.15 Medipatch Inc
15.15.1 Overview
15.15.2 Offerings
15.15.3 Key Financials
15.15.4 Business Segment & Geographic Overview
15.15.5 Key Market Developments
15.15.6 Key Strategies
